#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma metastatic Pulmonary hypertension Glycogen storage disease type II Lennox-Gastaut syndrome Human papilloma virus immunisation Spinal cord injury Craniocerebral injury Arrhythmogenic right ventricular dysplasia Prophylaxis against transplant rejection Malignant peritoneal neoplasm Fibrosarcoma Choroid melanoma Hereditary spastic paraplegia Chronic inflammatory demyelinating polyradiculoneuropathy Hyperchylomicronaemia More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Diagnostics Uterine leiomyosarcoma – Trials in Disease Nodal marginal zone B-cell lymphoma Nodal marginal zone B-cell lymphoma – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Haemophagocytic lymphohistiocytosis – Diagnostics Myelodysplastic syndrome – Treatment Erdheim-Chester disease – Diagnostics Behcet’s syndrome – Treatment Toxic epidermal necrolysis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sirexatamab Golimumab 68Ganota-Anti-Her2 Vhh1 Abt-494 Festuca Rubra Pollen Dutasteride ABIRATERONE DECANOATE SODIUM SULFIDE NONAHYDRATE Lovo-B Chloropyramine Hydrochloride Rtp-026 Sodium BENZYDAMINE HYDROCHLORIDE Argatroban Monohydrate Dordaviprone Evg321 Lenzumestrocel Disodium Levofolinate Mometasone Midazolam Betibeglogene Autotemcel More therapies…

    Learn about Your Condition

    Vaginal haemorrhage Narcolepsy Intestinal obstruction Atopic keratoconjunctivitis Depression Eyelid ptosis Actinic keratosis Immune thrombocytopenia Altered state of consciousness Cough Glaucoma Arterial tortuosity syndrome Ovarian cancer stage IV Nodular melanoma Cardiac arrest More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cx-037231
    • Cx-039776
    • Cx-044933
    Belgium Bulgaria Estonia Finland Germany
  • Study on Dexamethasone for Patients with Herpes Simplex Virus Encephalitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Human herpesvirus 6 encephalitis
    Investigated Drugs:
    • Dexamethasone
    France
  • Study on the Effects of VIR-2218 and VIR-3434 for Patients with Chronic Hepatitis D Infection

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Elebsiran
    • Tobevibart
    Bulgaria France Germany Italy The Netherlands Romania
  • Study on Letermovir for Preventing Cytomegalovirus in Heart Transplant Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Letermovir
    Slovenia
  • Study on the Safety and Effectiveness of VIR-2218, VIR-3434, and Peginterferon Alfa-2a for Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Elebsiran
    • Tobevibart
    Germany Romania
  • Study on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cabotegravir Sodium
    • Cabotegravir
    • Lenacapavir
    France
Previous Page
1 … 37 38 39 40 41 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!